Altaris, LLC acquires Tegria

Altaris, LLC has acquired Tegria Services Group, Inc., a move that underscores its commitment to expanding its footprint in the healthcare technology services sector. The acquisition, completed for an undisclosed sum, transitions Tegria from the hands of Providence St. Joseph Health to become a wholly owned portfolio company under Altaris. This strategic acquisition aims to position Tegria as a leading independent provider of outsourced technology solutions dedicated to enhancing healthcare providers' and payers' operations across North America and the UK.

Tegria, known for its expertise in clinical and technology consulting, managed services, and system optimization, will continue to serve Providence as a preferred technology services partner. It offers a wide range of services, from application hosting and data analytics to telemedicine and revenue cycle management. Tegria's reputation is bolstered by its high rankings in the “2025 Best in KLAS Software and Services Report,” where it was recognized for excellence in several categories, including payer IT consulting and clinical optimization.

For Altaris, the acquisition aligns with its long-standing strategy of investing in healthcare companies that promise to deliver operational efficiencies and cost reductions within the healthcare system. Altaris has a history of successful investments, with a portfolio that includes over 50 companies within the healthcare industry, covering various subsectors such as payer services, provider solutions, and technology.

In a market characterized by increasing demand for technology-driven healthcare solutions, this acquisition signifies a crucial step for Altaris in fortifying its healthcare technology offerings. As healthcare institutions continue to prioritize modernization and efficiency, Tegria's comprehensive service suite positions it to capitalize on these industry shifts, enhancing both patient and member experiences while improving operational outcomes.

Looking ahead, Tegria's integration within Altaris's portfolio will likely focus on expanding its service offerings and potentially seeking new market opportunities. While no immediate regulatory hurdles are apparent, the acquisition will demand careful integration planning to ensure seamless transition and continued service excellence for its healthcare clients.